Veranova Bidco v Johnson Matthey: fraud threshold in warranty claims and the limits of corporate knowledge

The Commercial Court has handed down a significant judgement on the intersection of warranty disclosure obligations and the fraud threshold required to circumvent contractual liability limitations in sale and purchase agreements. In Veranova Bidco LP v Johnson Matthey PLC & Ors [2026] EWHC 1021 (Comm), Mrs Justice Dias dismissed a high-value fraud claim despite finding a clear breach of the Key Contracts Warranty — a result that underscores the difficulty of establishing conscious dishonesty against senior corporate executives.

The background

The dispute arose from Johnson Matthey's 2021 sale of its pharmaceutical active ingredient business to Veranova Bidco, an affiliate of Altaris LLC. The SPA, signed on 16 December 2021, contained warranties including one that no key contract was being renegotiated in a way that would have an adverse effect on the business. Alvogen, the largest customer for buprenorphine hydrochloride (BHCL), had in October 2021 invoked a price-match clause following an offer from a Danish competitor, Chr. Olesen Synthesis A/S, to supply at approximately US$8/g — compared to the prevailing price of US$16/g.

Veranova argued this rendered the Key Contracts Warranty false and that, because the SPA precluded negligence-based warranty claims, the breach arose from the fraud of one or more of four senior JM executives who signed off on the transaction.

Warranty breach and disclosure

Dias J found the Key Contracts Warranty was indeed false. Price-match negotiations following a verified bona fide offer plainly constituted a renegotiation of a material term, and any conclusion would have had an adverse effect on the business. The Ordinary and Usual Course Warranty was not breached: price negotiations of this nature were entirely within the ordinary course of business and did not alter the nature, scope or manner of the company's activities.

The disclosure in the SPA letter — referring to "increased competition" and "ongoing pricing discussions" with Alvogen — was held to be insufficient. It did not fairly disclose that the price-match clause had been triggered by a verified offer at around US$8/g, or that the business would need to match it to retain its major customer. The judgement reaffirms, following Atten Bidco Ltd v Assassa [2025], that extraneous pre-contractual statements cannot supplement or qualify disclosure: the test is what a reasonable buyer could ascertain from within the four corners of the disclosure letter and data room.

The fraud threshold

The central legal issue concerned what is required to establish fraud or wilful misconduct in a corporate context sufficient to override the SPA's liability cap. Dias J rejected Veranova's primary case that knowledge of facts making a warranty false suffices, without any requirement that the relevant executive also appreciated the warranty existed and was falsified by that knowledge. Applying Armstrong v Strain [1951] and Stanford International Bank v HSBC [2021], she confirmed that it is not possible to aggregate the innocent states of mind of different individuals to arrive at a composite dishonest corporate state of mind.

The court accepted a formulation requiring that a single executive: knew the facts making the warranty false; had sufficient knowledge of the warranty's terms to appreciate their relevance; and knew or was reckless as to whether the warranty was thereby false. Applying this to each of the four executives — the CEO, CFO, Corporate Development Director, and a Senior Corporate Development Manager — the court found that none had the requisite combination of knowledge and awareness. Critically, the two executives who knew about the Olesen Offer (the CEO and Corporate Development Director) were found not to have had sufficient knowledge of the specific warranty terms; those who knew the warranty terms were found not to have known about the offer itself.

The judgement also notes the absence of any credible motive for fraud — the sale price had already fallen sharply, the executives were not enthusiastic about the transaction, and any concealment was bound to unravel once Veranova assumed control of the business and its management team.

The claim accordingly failed in its entirety. Dias J observed that the contractual framework Veranova agreed to — excluding negligence-based claims — left it without remedy despite a genuine failure of disclosure, one the court found objectively ought to have been made.